Inhibitory effect of cepharanthine on dendritic cell activation and function

Area of Science:

• Immunology
• Cell Biology
• Pharmacology

Background:

• Dendritic cells (DCs) bridge innate and adaptive immunity, serving as key regulators of immune responses.
• DCs are critical targets for managing excessive immune reactions, including autoimmune diseases and allergies.

Purpose of the Study:

• To investigate the immunomodulatory effects of cepharanthine (CEP), a biscoclaurine alkaloid, on murine dendritic cells (DCs) in vitro.
• To evaluate CEP's impact on DC function, including antigen uptake, maturation, and T cell activation.

Main Methods:

• Murine DCs were treated with varying concentrations of CEP.
• Antigen uptake, expression of costimulatory molecules and MHC class I, and production of cytokines (IL-6, TNF-α) were assessed.
• The effect of CEP-treated DCs on allogeneic T cell proliferation and interferon-γ production was evaluated.

Main Results:

• CEP inhibited DC antigen uptake at concentrations of 1-5 μg/ml.
• CEP suppressed lipopolysaccharide (LPS)-induced DC maturation, evidenced by reduced costimulatory molecule and MHC class I expression.
• CEP decreased IL-6 and TNF-α production in LPS-stimulated DCs and impaired their ability to stimulate T cell proliferation and interferon-γ release.

Conclusions:

• Cepharanthine exhibits significant immunoregulatory properties by modulating DC function.
• CEP's ability to inhibit DC maturation and T cell activation suggests its therapeutic potential for autoimmune diseases and allergies.